1096-P: Determining the Optimal Fasting Glucose Target for Patients with Type 2 Diabetes: Results of the FPG Goal Trial

1096-P: Determining the Optimal Fasting Glucose Target for Patients with Type 2 Diabetes: Results of the FPG Goal Trial

Background: The optimal fasting glucose target to achieve an HbA1c 7% to ≤10.5%) on 1-3 OADs to 1 of 3 self-monitored fasting blood glucose (FBG) target groups: ≤5.6 mmol/L (Group 1), ≤6.1 mmol/L (Group 2), or ≤7.0 mmol/L (Group 3). The lowest of 3 consecutive FBG values was used for insulin glargin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Diabetes (New York, N.Y.) N.Y.), 2019-06, Vol.68 (Supplement_1)
Hauptverfasser: YANG, WENYING, MA, JIANHUA, YUAN, GUOYUE, LI, LING, ZHANG, MIN, LU, YIBING, YE, XINHUA, SONG, WEIHONG, LIU, MING, WU, JUN, CHEN, RIQIU, CUI, NAN, LI, YUNGUANG, ZHANG, XIA, YANG, JIN-KUI
Format: Artikel
Sprache:eng
Schlagworte:
Diabetes
Diabetes mellitus
Diabetes mellitus (non-insulin dependent)
Insulin
Insulin secretion
Lipid metabolism
Remission
Secretion
Smoking
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: The optimal fasting glucose target to achieve an HbA1c 7% to ≤10.5%) on 1-3 OADs to 1 of 3 self-monitored fasting blood glucose (FBG) target groups: ≤5.6 mmol/L (Group 1), ≤6.1 mmol/L (Group 2), or ≤7.0 mmol/L (Group 3). The lowest of 3 consecutive FBG values was used for insulin glargine 100 U/ml titration decisions. Primary endpoint was the proportion of patients achieving an HbA1c
ISSN:0012-1797
1939-327X
DOI:10.2337/db19-1096-P